Trial Profile
A second clinical study in healthy volunteers investigating Micropump sodium oxybate
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2021
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Narcolepsy
- Focus Adverse reactions; Pharmacokinetics
- 02 Mar 2021 According to an Avadel Pharmaceuticals media release, data from this trial has been published in Clinical Therapeutics.
- 18 Sep 2019 According to an Avadel Pharmaceuticals media release, data will be presented at the World Sleep 2019 Congress, which is taking place from September 20-25, 2019 at the Vancouver Convention Centre, Vancouver, Canada.
- 03 Jan 2017 This trial was planned by Flamel Technologies. The company has completed cross-border merger and became Avadel Pharmaceuticals plc, according to a Flamel Technologies media release.